Evidence map›Paper›PMID 38195510›Full record

ArticleCell communication and signaling : CCS2024

Transcriptomic signatures of individual cell types in cerebral cavernous malformation.

Ying Li, Romuald Girard, Abhinav Srinath, Diana Vera Cruz, Cezary Ciszewski, Chang Chen, Rhonda Lightle, Sharbel Romanos, Je Yeong Sone, Thomas Moore and 11 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 3 countries.

Ying Li *Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.ORCID 0000-0002-4107-5442
Romuald Girard *Department of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Abhinav SrinathDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Diana Vera CruzCenter for Research Informatics, The University of Chicago, Chicago, IL, USA.
Cezary CiszewskiHuman Disease and Immune Discovery Core, The University of Chicago, Chicago, IL, USA.
Chang ChenCenter for Research Informatics, The University of Chicago, Chicago, IL, USA.
Rhonda LightleDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Sharbel RomanosDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Je Yeong SoneDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Thomas MooreDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Dorothy DeBiasseDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Agnieszka StadnikDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Justine J LeeDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.
Robert ShenkarDepartment of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA.ORCID 0000-0002-1300-6845
Janne KoskimäkiDepartment of Neurosurgery, Division of Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.
Miguel A Lopez-RamirezDepartment of Medicine, University of California, La Jolla, San Diego, CA, USA.
Douglas A MarchukDepartment of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC, USA.
Mark H GinsbergDepartment of Medicine, University of California, La Jolla, San Diego, CA, USA.
Mark L KahnDepartment of Medicine and Cardiovascular Institute, University of Pennsylvania, Philadelphia, PA, USA.
Changbin Shi *Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Issam A Awad *Department of Neurological Surgery, Neurovascular Surgery Program, The University of Chicago, Chicago, IL, USA. iawad@uchicago.edu.ORCID 0000-0003-1510-602X
University of Chicago · USHarbin Medical University · CNUniversity of California San Diego · USDuke University · USUniversity of Pennsylvania · USUniversity of Turku · FI

Funding

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)T32HD007009 · NICHD · UNIVERSITY OF CHICAGO · PI NANCY B SCHWARTZ · 1985 to 2026
$13.0M
Somatic mutation(s) and cellular changes in CCM pathogenesisP01NS092521 · NINDS · DUKE UNIVERSITY · PI KAHN, MARK L · 2015 to 2024
$12.9M
Training In Cardiovascular Physiology & PharmacologyT32HL007444 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Ju Chen, Robert Scott Ross · 1985 to 2026
$11.1M
UCSD PRIDE Faculty Development Program in Cardiovascular SciencesR25HL145817 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Robert Scott Ross, Joann Trejo · 2019 to 2026
$3.3M
Short Term Aging-Related Research ProgramT35AG029795 · NIA · UNIVERSITY OF CHICAGO · PI Vineet Arora, DAVID O MELTZER · 2008 to 2026
$1.4M
NHLBI NIH HHS R25 HL145817NHLBI NIH HHS T32 HL007444NIA NIH HHS T35 AG029795NICHD NIH HHS T32 HD007009NINDS NIH HHS P01 NS092521
6 · The paper itself

Abstract

Cerebral cavernous malformation (CCM) is a hemorrhagic neurovascular disease with no currently available therapeutics. Prior evidence suggests that different cell types may play a role in CCM pathogenesis. The contribution of each cell type to the dysfunctional cellular crosstalk remains unclear. Herein, RNA-seq was performed on fluorescence-activated cell sorted endothelial cells (ECs), pericytes, and neuroglia from CCM lesions and non-lesional brain tissue controls. Differentially Expressed Gene (DEG), pathway and Ligand-Receptor (LR) analyses were performed to characterize the dysfunctional genes of respective cell types within CCMs. Common DEGs among all three cell types were related to inflammation and endothelial-to-mesenchymal transition (EndMT). DEG and pathway analyses supported a role of lesional ECs in dysregulated angiogenesis and increased permeability. VEGFA was particularly upregulated in pericytes. Further pathway and LR analyses identified vascular endothelial growth factor A/ vascular endothelial growth factor receptor 2 signaling in lesional ECs and pericytes that would result in increased angiogenesis. Moreover, lesional pericytes and neuroglia predominantly showed DEGs and pathways mediating the immune response. Further analyses of cell specific gene alterations in CCM endorsed potential contribution to EndMT, coagulation, and a hypoxic microenvironment. Taken together, these findings motivate mechanistic hypotheses regarding non-endothelial contributions to lesion pathobiology and may lead to novel therapeutic targets. Video Abstract.

Indexed as

Hemangioma, Cavernous, Central Nervous SystemVascular Endothelial Growth Factor AEndothelial CellsGene Expression ProfilingHumansTranscriptomeTumor MicroenvironmentVascular Endothelial Growth Factor ACell–cell interactionCerebral cavernous malformationTranscriptomeVEGFA/VEGFR2

Identifiers

PMID38195510
PMCPMC10775676
OpenAlexW4390779273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.